AG-015

N/A

Report date: 2025/06/11 10:29:14

Base Information

Drug NameAG-015

Drug Alias NameLactococcus lactis anti-IL-27 (Precigen)Lactococcus lactis anti-IL-27 (Intrexon)Lactococcus lactis anti-IL-27 (ActoGeniX)AG-015LL-IL-27

ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionInterleukin-27 subunit alpha inhibitors

TargetsInterleukin-27

Therapy Area/IndicationsAutoimmune DiseasesCeliac DiseaseInflammatory Bowel Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesPrecigen Inc

Inactive Companies +[1] N/A

Active IndicationsAutoimmune DiseasesCeliac DiseaseInflammatory Bowel Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A